Lenvatinib
Lenvatinib (E7080) is an orally active multi-target tyrosine kinase inhibitor with potent activity against VEGFR2/3, FGFR1-4, RET, KIT, and PDGFR. It demonstrates robust anti-tumor effects in both in vitro assays and in vivo models, supporting its research use in oncology, particularly for studying angiogenesis and tumor proliferation pathways.
Product Specifications
CAS Number
417716-92-8
Product Name Alternative
E7080
Field of Research
Cardiovascular Research
Purity
>98%
Bioactivity
VEGFR kinase inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 20 mg/ml)
Smiles
O (C=1C2=C (C=C (OC) C (C (N) =O) =C2) N=CC1) C3=CC (Cl) =C (NC (NC4CC4) =O) C=C3
Molecular Formula
C21H19ClN4O4
Molecular Weight
426.85
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[3-Chloro-4-[[ (cyclopropylamino) carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2022390-01 24 Strip Well
Human Transglutaminase 3, Epidermal (TGM3) ELISA Kit
Sign In for Pricing
View Details MBS2022390-02 48 Well
Human Transglutaminase 3, Epidermal (TGM3) ELISA Kit
Sign In for Pricing
View Details MBS2022390-03 96 Well
Human Transglutaminase 3, Epidermal (TGM3) ELISA Kit
Sign In for Pricing
View Details MBS2022390-04 5x 96 Well
Human Transglutaminase 3, Epidermal (TGM3) ELISA Kit
Sign In for Pricing
View Details MBS2022390-05 10x 96 Well
Human Transglutaminase 3, Epidermal (TGM3) ELISA Kit
Sign In for Pricing
View Details 